The U.S. Food and Drug Administration (FDA) today announced the Approval of Moderna’s SpikeVax COVID-19 vaccine for adults 18 years and older.
SpikeVax has received Approvals from regulators in more than 70 countries, including Canada, Japan, Israel, the European Union, the UK.
Spikevax has the same formulation as the Authorized Moderna COVID-19 Vaccine and is administered as a primary series of two doses, one month apart.
Read More
